Werner Heinz

9.5k total citations · 1 hit paper
91 papers, 3.5k citations indexed

About

Werner Heinz is a scholar working on Infectious Diseases, Epidemiology and Oncology. According to data from OpenAlex, Werner Heinz has authored 91 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Infectious Diseases, 66 papers in Epidemiology and 21 papers in Oncology. Recurrent topics in Werner Heinz's work include Antifungal resistance and susceptibility (67 papers), Fungal Infections and Studies (56 papers) and Infectious Diseases and Mycology (20 papers). Werner Heinz is often cited by papers focused on Antifungal resistance and susceptibility (67 papers), Fungal Infections and Studies (56 papers) and Infectious Diseases and Mycology (20 papers). Werner Heinz collaborates with scholars based in Germany, United States and Belgium. Werner Heinz's co-authors include Oliver A. Cornely, Johan Maertens, Hermann Einsele, Dieter Buchheidt, Raoul Herbrecht, Cornelia Lass‐Flörl, Andrew J. Ullmann, Georg Maschmeyer, Jörg Janne Vehreschild and Gerda Silling and has published in prestigious journals such as Blood, Annals of Internal Medicine and Journal of Clinical Microbiology.

In The Last Decade

Werner Heinz

87 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Combination Antifungal Therapy for Invasive Aspergillosis

2015 333 citations Raoul Herbrecht, Oliver A. Cornely et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Werner Heinz Germany	34	2.7k	2.6k	783	372	302	91	3.5k
Z. Erjavec Netherlands	16	1.9k 0.7×	1.8k 0.7×	648 0.8×	293 0.8×	200 0.7×	24	2.5k
Harrys A. Torres United States	35	1.7k 0.6×	2.4k 0.9×	586 0.7×	271 0.7×	158 0.5×	114	3.6k
Marisa H. Miceli United States	28	1.9k 0.7×	1.7k 0.7×	353 0.5×	296 0.8×	297 1.0×	85	3.0k
Corrado Girmenia Italy	36	3.2k 1.2×	3.0k 1.2×	1.2k 1.5×	372 1.0×	541 1.8×	138	4.8k
J. Hiemenz United States	13	1.4k 0.5×	1.3k 0.5×	398 0.5×	278 0.7×	225 0.7×	23	2.0k
B.E. de Pauw Netherlands	32	1.8k 0.7×	1.7k 0.6×	988 1.3×	278 0.7×	332 1.1×	119	3.4k
Ben de Pauw Netherlands	21	2.6k 1.0×	2.5k 1.0×	1.1k 1.4×	366 1.0×	261 0.9×	41	4.0k
Pietro Martino Italy	22	1.3k 0.5×	1.3k 0.5×	789 1.0×	168 0.5×	219 0.7×	42	2.3k
Stephen Dummer United States	19	1.7k 0.6×	1.8k 0.7×	632 0.8×	260 0.7×	101 0.3×	30	2.6k
J Tollemar Sweden	30	1.7k 0.6×	1.7k 0.7×	463 0.6×	177 0.5×	132 0.4×	87	3.1k

Countries citing papers authored by Werner Heinz

Since Specialization

Citations

This map shows the geographic impact of Werner Heinz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Werner Heinz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Werner Heinz more than expected).

Fields of papers citing papers by Werner Heinz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Werner Heinz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Werner Heinz. The network helps show where Werner Heinz may publish in the future.

Co-authorship network of co-authors of Werner Heinz

This figure shows the co-authorship network connecting the top 25 collaborators of Werner Heinz. A scholar is included among the top collaborators of Werner Heinz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Werner Heinz. Werner Heinz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cruciani, Mario, P. Lewis White, Rosemary A. Barnes, et al.. (2023). An Overview of Systematic Reviews of Polymerase Chain Reaction (PCR) for the Diagnosis of Invasive Aspergillosis in Immunocompromised People: A Report of the Fungal PCR Initiative (FPCRI)—An ISHAM Working Group. Journal of Fungi. 9(10). 967–967. 8 indexed citations

Groll, Andreas H., Dieter Buchheidt, Birgit Willinger, et al.. (2021). State of Medical Mycology at German Academic Medical Centres: A Survey of the German‐Speaking Mycological Society (DMYKG) and the Paul‐Ehrlich‐Society for Chemotherapy (PEG). Mycoses. 64(10). 1177–1182. 1 indexed citations

Cruciani, Mario, P. Lewis White, Carlo Mengoli, et al.. (2020). The impact of anti-mould prophylaxis onAspergillusPCR blood testing for the diagnosis of invasive aspergillosis. Journal of Antimicrobial Chemotherapy. 76(3). 635–638. 20 indexed citations

Heimann, Sebastian, Olaf Penack, Werner Heinz, et al.. (2019). Intravenous and tablet formulation of posaconazole in antifungal therapy and prophylaxis: A retrospective, non-interventional, multicenter analysis of hematological patients treated in tertiary-care hospitals. International Journal of Infectious Diseases. 83. 130–138. 11 indexed citations

Maertens, Johan, Dominik Selleslag, Werner Heinz, et al.. (2018). Treatment outcomes in patients with proven/probable vs possible invasive mould disease in a phase III trial comparing isavuconazole vs voriconazole. Mycoses. 61(11). 868–876. 8 indexed citations

Springer, Jan, P. Lewis White, Johanna Kessel, et al.. (2017). A Comparison of Aspergillus and Mucorales PCR Testing of Different Bronchoalveolar Lavage Fluid Fractions from Patients with Suspected Invasive Pulmonary Fungal Disease. Journal of Clinical Microbiology. 56(2). 30 indexed citations

Heinz, Werner, Dieter Buchheidt, Maximilian Christopeit, et al.. (2017). Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Annals of Hematology. 96(11). 1775–1792. 100 indexed citations

Döring, Michaela, Hartwig Klinker, Judith Feucht, et al.. (2016). Posaconazole plasma concentrations in pediatric patients receiving antifungal prophylaxis during neutropenia. Medical Mycology. 55(4). myw091–myw091. 20 indexed citations

Ullmann, Andrew J., Martin Schmidt‐Hieber, Hartmut Bertz, et al.. (2016). Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016. Annals of Hematology. 95(9). 1435–1455. 133 indexed citations

10.

Springer, Jan, Michaela Lackner, David Nachbaur, et al.. (2015). Prospective multicentre PCR-based Aspergillus DNA screening in high-risk patients with and without primary antifungal mould prophylaxis. Clinical Microbiology and Infection. 22(1). 80–86. 55 indexed citations

11.

Heinz, Werner, Hartwig Klinker, Judith Feucht, et al.. (2015). Posaconazole plasma concentration in pediatric patients receiving antifungal prophylaxis after allogeneic hematopoietic stem cell transplantation. Medical Mycology. 54(2). 128–137. 19 indexed citations

12.

Schwab, Katjana, Corinna Hahn‐Ast, Werner Heinz, et al.. (2013). Tigecycline in febrile neutropenic patients with haematological malignancies: a retrospective case documentation in four university hospitals. Infection. 42(1). 97–104. 13 indexed citations

13.

Maschmeyer, Georg, Werner Heinz, Bernd Hertenstein, et al.. (2012). Immediate versus deferred empirical antifungal (IDEA) therapy in high-risk patients with febrile neutropenia: a randomized, double-blind, placebo-controlled, multicenter study. European Journal of Clinical Microbiology & Infectious Diseases. 32(5). 679–689. 15 indexed citations

14.

Klinker, Hartwig, Marianne Abele‐Horn, Dennis Tappe, et al.. (2012). Epidemiology ofCandidablood stream infections in patients with hematological malignancies or solid tumors. Medical Mycology. 50(1). 50–55. 58 indexed citations

15.

Heinz, Werner, Gerlinde Egerer, Heinrich Lellek, Angelika Boehme, & Jochen Greiner. (2012). Posaconazole after previous antifungal therapy with voriconazole for therapy of invasive aspergillus disease, a retrospective analysis. Mycoses. 56(3). 304–310. 40 indexed citations

16.

Reinwald, Mark, Michael Hummel, Birgit Spieß, et al.. (2012). Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies. Journal of Antimicrobial Chemotherapy. 67(9). 2260–2267. 80 indexed citations

17.

Cornely, Oliver A., Angelika Böhme, Dieter Buchheidt, et al.. (2008). Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology. Haematologica. 94(1). 113–122. 137 indexed citations

18.

Böhme, Angelika, Markus Ruhnke, Dieter Buchheidt, et al.. (2008). Treatment of invasive fungal infections in cancer patients—Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Annals of Hematology. 88(2). 97–110. 90 indexed citations

19.

Heinz, Werner & Hermann Einsele. (2008). Caspofungin for treatment of invasive aspergillus infections. Mycoses. 51(s1). 47–57. 12 indexed citations

20.

Kurzai, Oliver, Werner Heinz, & Fritz A. Mühlschlegel. (1999). ASM—Conference ‘Candida and Candidiasis’. March 1–4, 1999. Charleston SC, USA. Mycoses. 42(5-6). 427–430. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact